A semi-quantitative, rapid, point of care SARS-CoV-2 serologic assay predicts neutralizing antibody levels

The ongoing COVID-19 pandemic has caused millions of deaths and the continued emergence of new variants suggests continued circulation in the human population. In the current time of vaccine availability and new therapeutic development, including antibody-based therapies, many questions about long-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Markmann, Alena J., Bhowmik, D. Ryan, Jiang, Baowei, Van Hoy, Michael, Wang, Frank, Hou, Yixuan J., Baric, Ralph S., de Silva, Aravinda M., Bartelt, Luther A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312490/
https://www.ncbi.nlm.nih.gov/pubmed/37398270
http://dx.doi.org/10.1101/2023.05.30.542314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312490/
https://www.ncbi.nlm.nih.gov/pubmed/37398270
http://dx.doi.org/10.1101/2023.05.30.542314

Ejemplares similares